Evidence map›Paper›PMID 24122218›Full record

ArticleCancer2014

Body mass and smoking are modifiable risk factors for recurrent bladder cancer.

Asaf Wyszynski, Sam A Tanyos, Judy R Rees, Carmen J Marsit, Karl T Kelsey, Alan R Schned, Eben M Pendleton, Maria O Celaya, Michael S Zens, Margaret R Karagas and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 8 pooled it
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 8 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Guideline
  7. Survivorship: healthy lifestyles, version 2.2014.Journal of the National Comprehensive Cancer Network : JNCCN · 2014
    Guideline
  8. Pooled it
  9. Effect of smoking on the recurrence and progression of non-muscle-invasive bladder cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  10. Article
  11. Article
  12. Evaluation of the Effects of Opium on the Expression ofBladder cancer (Amsterdam, Netherlands) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Impact of exercise on physical health status in bladder cancer patients.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Asaf WyszynskiDepartment of Community and Family Medicine, Section of Biostatistics and Epidemiology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire; Program in Experimental and Molecular Medicine, Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
Sam A Tanyos
Judy R Rees
Carmen J Marsit
Karl T Kelsey
Alan R Schned
Eben M Pendleton
Maria O Celaya
Michael S Zens
Margaret R Karagas
Angeline S Andrew
Dartmouth Psychiatric Research Center · USDartmouth College · USBrown University · US

Funding

VARIATION IN BIOACCUMULATION AND BIOMAGNIFICATION OF METALS IN NORTHERN US LAKESP42ES007373 · NIEHS · DARTMOUTH COLLEGE · PI CHEN, CELIA Y · 1995 to 2019
$52.0M
Translational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Brent Andrew Coull · 1985 to 2026
$44.6M
THE ROLE OF CAL IN CIF-MEDIATED DEGRADATION OF CFTRP20RR018787 · NCRR · DARTMOUTH COLLEGE · PI STANTON, BRUCE A. · 2003 to 2011
$21.9M
VANADIUM AND HUMAN HEALTHP42ES005947 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KELSEY, KARL TIMOTHY · 1992 to 2006
$19.6M
NH CANCER REGISTRY NH COMPREHE CANCER CONTR PROG NH BREAST & CERVICAL CANCER PROGU58DP000798 · DP · NH STATE DEPT/HLTH STATISTICS/DATA MGMT · PI MONTERO, JOSE THEIR · 2007 to 2011
$12.1M
NONMELANOMA SKIN CANCER IN NEW HAMPSHIRER01CA057494 · NCI · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA · 1993 to 2015
$10.9M
Quantitative Biology Research InstituteP20GM103534 · NIGMS · DARTMOUTH COLLEGE · PI AMOS, CHRISTOPHER I. · 2012 to 2016
$8.6M
MOLECULAR EPIDEMIOLOGY OF NON-MELANOMA SKIN CANCERR01CA082354 · NCI · UNIVERSITY OF MINNESOTA · PI NELSON, HEATHER HAMMOND · 1999 to 2011
$4.2M
QUANTITATIVE BIOLOGY RESEARCH INSTITUTEP20RR024475 · NCRR · DARTMOUTH COLLEGE · PI MOORE, JASON H. · 2011 to 2011
$2.3M
Bladder Cancer Prognostic IndicatorsK07CA102327 · NCI · DARTMOUTH COLLEGE · PI ANDREW, ANGELINE SANDERSON · 2005 to 2009
$819k
MicroRNA dysregulation and bladder cancer prognosisR21CA182659 · NCI · DARTMOUTH COLLEGE · PI ANDREW, ANGELINE SANDERSON · 2014 to 2015
$388k
Comprehensive Assessment of Bladder Cancer Genetic SusceptibilityR03CA121382 · NCI · DARTMOUTH COLLEGE · PI ANDREW, ANGELINE SANDERSON · 2006 to 2007
$158k
NCCDPHP CDC HHS U58 DP000798NCCDPHP CDC HHS U58/DP000798NCI NIH HHS CA121382NCI NIH HHS CA82354NCI NIH HHS K07 CA102327NCI NIH HHS K07CA102327NCI NIH HHS R01 CA057494NCI NIH HHS R01 CA082354NCI NIH HHS R03 CA121382NCI NIH HHS R21 CA182659NCRR NIH HHS P20 RR018787NCRR NIH HHS P20 RR024475NCRR NIH HHS RR018787NIEHS NIH HHS ES00002NIEHS NIH HHS ES05947NIEHS NIH HHS ES07373NIEHS NIH HHS P30 ES000002NIEHS NIH HHS P42 ES005947NIEHS NIH HHS P42 ES007373NIGMS NIH HHS P20 GM103534
6 · The paper itself

Abstract

backgroundIn the Western world, bladder cancer is the fourth most common cancer in men and the eighth most common in women. Recurrences frequently occur, and continued surveillance is necessary to identify and treat recurrent tumors. Efforts to identify risk factors that are potentially modifiable to reduce the rate of recurrence are needed.

methodsCigarette smoking behavior and body mass index were investigated at diagnosis for associations with bladder cancer recurrence in a population-based study of 726 patients with bladder cancer in New Hampshire, United States. Patients diagnosed with non-muscle invasive urothelial cell carcinoma were followed to ascertain long-term prognosis. Analysis of time to recurrence was performed using multivariate Cox regression models.

resultsSmokers experienced shorter time to recurrence (continuing smoker hazard ratio [HR] = 1.51, 95% confidence interval [CI] = 1.08-2.13). Although being overweight (body mass index > 24.9 kg/m(2) ) at diagnosis was not a strong independent factor (HR = 1.33, 95% CI = 0.94-1.89), among continuing smokers, being overweight more than doubled the risk of recurrence compared to smokers of normal weight (HR = 2.67, 95% CI = 1.14-6.28).

conclusionsThese observational results suggest that adiposity is a risk factor for bladder cancer recurrence, particularly among tobacco users. Future intervention studies are warranted to evaluate whether both smoking cessation and weight reduction strategies reduce bladder tumor recurrences.

Indexed as

Body Mass IndexAdiposityAdultAgedFemaleHumansMaleMiddle AgedNeoplasm Recurrence, LocalProportional Hazards ModelsRisk FactorsSmokingUrinary Bladder Neoplasmsbladder cancerbody mass indexobesityrecurrencesmokingurothelial cell carcinoma

Identifiers

PMID24122218
PMCPMC3946933
OpenAlexW1482328974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.